Palvella Therapeutics, Inc. (PVLA) Shareholders’ equity 2016–2023
Palvella Therapeutics, Inc. (PVLA) shareholders’ equity at each fiscal year-end, per SEC filings.
-$74.5MFY2023 · since FY2016: $25.2M → -$74.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$74.5M | +20.6% |
| FY2022 | -$93.8M | -284.8% |
| FY2021 | $50.8M | +63.6% |
| FY2020 | $31.0M | -39.6% |
| FY2019 | $51.4M | +28.6% |
| FY2018 | $39.9M | +246.6% |
| FY2017 | $11.5M | -54.3% |
| FY2016 | $25.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice